Asthma
| Drug | ||
|---|---|---|
| Cortisone | ||
| Cromolyn | ||
| Ephedrine | ||
| Hydrocortisone |
| Drug | ||
|---|---|---|
| Budesonide-Formoterol | ||
| Fluticasone | ||
| Fluticasone-Salmeterol | ||
| Fluticasone-Vilanterol | ||
| Dupilumab | ||
| Tiotropium | ||
| Mometasone-Formoterol | ||
| Omalizumab | ||
| Fluticasone Furoate | ||
| Budesonide | ||
| Ipratropium Bromide | ||
| Mepolizumab | ||
| Albuterol | ||
| Aminophylline | ||
| Atropine | ||
| Beclomethasone | ||
| Benralizumab | ||
| Ciclesonide | ||
| Cortisone | ||
| Cromolyn | ||
| Dexamethasone | ||
| Dexamethasone Sod Phosphate-PF | ||
| Dexamethasone Sodium Phosphate | ||
| Dyphylline | ||
| Ephedrine | ||
| Epinephrine | ||
| Flunisolide | ||
| Formoterol Fumarate | ||
| Hydrocortisone | ||
| Hydrocortisone Sod Succinate | ||
| Levalbuterol | ||
| Levalbuterol Tartrate | ||
| Metaproterenol | ||
| Methylprednisolone | ||
| Methylprednisolone Acetate | ||
| Methylprednisolone Sodium Succ | ||
| Mometasone | ||
| Montelukast | ||
| Prednisolone | ||
| Prednisolone Acetate | ||
| Prednisolone Sodium Phosphate | ||
| Prednisone | ||
| Reslizumab | ||
| Salmeterol | ||
| Terbutaline | ||
| Theophylline | ||
| Triamcinolone | ||
| Triamcinolone Acetonide | ||
| Zafirlukast | ||
| Zileuton |
Copyright © 2025 TraceGains, Inc. All rights reserved.
Learn more about TraceGains, the company.
The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2025.